JP Morgan Chase’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
NCM
CCM
PFCS
GCGM
DMC
MC
MCM
JP Morgan Chase's GUTS Position: Q2 2026 in Review
JP Morgan Chase increased its Fractyl Health (GUTS) stake by 63% in Q2 2026, buying an estimated $420 and bringing the position to 1,523 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #7301.
JP Morgan Chase first reported a position in GUTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $287K in Q1 2024. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.
- JP Morgan Chase held 1,523 shares of Fractyl Health worth $1.21K as of Q2 2026.
- JP Morgan Chase bought 589 Fractyl Health shares in Q2 2026, an estimated $420.
- Fractyl Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7301 holding.
- JP Morgan Chase first reported a position in Fractyl Health in Q1 2024 and has held it in 9 quarters since.
- JP Morgan Chase's Fractyl Health position peaked at $287K in Q1 2024.
- 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.